Related Experiment Videos

The burden of hyperlipidaemia and diabetes in cardiovascular diseases

Marijan Merkler1, Zeljko Reiner

  • 1Department of Internal Medicine, University Hospital Center, Zagreb, Croatia.

Fundamental & Clinical Pharmacology
|November 16, 2007
PubMed

Insights

High rates of cardiovascular diseases (CVD) are linked to hyperlipidaemia and diabetes, especially in Europe. Prevention programs targeting these major risk factors are crucial, particularly in urban areas of low- and medium-income countries.

Area of Science:

  • Cardiology
  • Public Health
  • Metabolic Diseases

Background:

  • Cardiovascular diseases (CVD) pose a significant global health challenge.
  • Hyperlipidaemia and diabetes are identified as primary risk factors contributing to CVD incidence.
  • High CVD rates are prevalent across European nations.

Purpose of the Study:

  • To highlight the escalating prevalence of hyperlipidaemia and diabetes as CVD risk factors.
  • To emphasize the growing concern of these conditions in urban populations of low- and medium-income countries.
  • To advocate for prioritized planning and implementation of CVD prevention strategies.

Main Methods:

  • Analysis of mean incident rates for hyperlipidaemia and diabetes in relation to CVD.
  • Review of epidemiological data on CVD risk factors across European countries.
  • Assessment of the trend of these risk factors in urban populations globally.

Main Results:

  • Cardiovascular disease incidence is notably high in European countries.
  • Hyperlipidaemia and diabetes are increasingly prevalent, particularly in urban settings of lower-income nations.
  • The rate of onset for these risk factors is accelerating globally.

Conclusions:

  • Hyperlipidaemia and diabetes represent critical, modifiable risk factors for cardiovascular diseases.
  • Urgent and prioritized public health interventions are necessary for CVD prevention.
  • Targeted programs focusing on controlling hyperlipidaemia and diabetes are essential for reducing CVD burden.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...